Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07IOX
|
||||
| Former ID |
DNC010117
|
||||
| Drug Name |
2-(N-tert-Butylamino)-3'-chlorooctanophenone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530442] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H28ClNO
|
||||
| Canonical SMILES |
CCCCCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C
|
||||
| InChI |
1S/C18H28ClNO/c1-5-6-7-8-12-16(20-18(2,3)4)17(21)14-10-9-11-15(19)13-14/h9-11,13,16,20H,5-8,12H2,1-4H3
|
||||
| InChIKey |
HHZNTCLXZVSLGW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [530442] | |
| Sodium-dependent dopamine transporter | Target Info | Inhibitor | [530442] | ||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| WikiPathways | Monoamine Transport | ||||
| NRF2 pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport | |||||
| Dopaminergic Neurogenesis | |||||
| Parkinsons Disease Pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.